Trulieve Cannabis (TSE:TRU) Upgraded by Cormark to Moderate Buy Rating

Cormark upgraded shares of Trulieve Cannabis (TSE:TRU) from a hold rating to a moderate buy rating in a research note released on Monday,Zacks.com reports.

TRU has been the topic of several other reports. Atb Cap Markets upgraded shares of Trulieve Cannabis from a “hold” rating to a “strong-buy” rating in a report on Monday, December 9th. Craig Hallum upgraded shares of Trulieve Cannabis to a “strong-buy” rating in a report on Wednesday, February 26th.

Trulieve Cannabis Stock Performance

Insider Buying and Selling at Trulieve Cannabis

In related news, Senior Officer Wes Getman bought 9,500 shares of the business’s stock in a transaction on Friday, December 13th. The shares were bought at an average cost of C$7.02 per share, for a total transaction of C$66,702.35.

Trulieve Cannabis Company Profile

TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.